A BiTE targeting Wilms’ tumor protein (WT1) led to the expansion of secondary T cell clones (with specificity for tumor-associated antigens other than WT1) in in vitro co-cultures of patient PBMCs with autologous tumor cells [46]. Here, WT1 is linked to neoplasm.